.png)
The global Hemp Herbal Cigarettes with CBD market is entering a high-growth phase driven by rising consumer demand for nicotine-free alternatives, wellness-oriented smoking products, and regulatory shifts encouraging low-THC hemp innovations. The market was valued at USD 0.57 billion in 2024, is estimated to reach USD 0.66 billion in 2025, and is projected to expand significantly to USD 1.94 billion by 2034, reflecting a strong CAGR of 12.67% over the forecast period. Consumer adoption patterns highlight new motivations reshaping the category: 42% of users prefer CBD cigarettes as nicotine-free substitutes, 31% use hemp prerolls for wellness and relaxation benefits, and 36% of recreational buyers cite flavor innovation including terpene-rich blends as a primary purchase driver. Additionally, nearly 28% of global retailers introduced CBD-based herbal cigarette product lines in 2024–2025, signaling rapid expansion in distribution and SKU diversification across convenience stores, dispensaries, and online platforms.
The United States remains the most influential market within the broader medical cannabis ecosystem, indirectly supporting demand for compliant hemp-CBD smoking products. The U.S. medical cannabis segment accounted for nearly 41% of total global revenue in 2025, making it the world’s largest national market. Valued at USD 18.1 billion in 2024, the market is projected to rise to USD 20.4 billion in 2025, with expectations to surpass USD 50 billion by 2033, driven by a robust CAGR of 12.7% during 2025–2033. This accelerating medical adoption creates a favorable regulatory and commercial environment for hemp-derived CBD inhalable products especially in regions where THC-rich cannabis remains restricted but hemp prerolls are permitted.
How Big Is the Hemp Herbal Cigarettes with CBD Industry in 2025?
The Hemp Herbal Cigarettes with CBD industry continues its rapid upward trajectory in 2025, driven by a combination of nicotine-free lifestyle adoption, wellness-linked consumption, and expanding regulatory clarity across major markets. In 2025, the global industry reached an estimated USD 0.66 billion, reflecting a strong increase from USD 0.57 billion in 2024, and is on track to exceed USD 1.94 billion by 2034, supported by a sustained 12.67% CAGR. North America alone accounts for 48% of global revenue, with the United States contributing over USD 0.34 billion making it the world’s single-largest national market for CBD cigarette consumption. Rising consumer preference for alternative smoking formats continues to gain momentum: 42% of users choose CBD cigarettes for nicotine-free substitution, 31% for wellness relief, and 36% cite flavor-enhanced hemp prerolls as their primary purchase rationale.
Within the U.S. market, the rapid expansion of the broader cannabis ecosystem strongly influences hemp cigarette adoption. The U.S. medical cannabis market generated USD 20.4 billion in 2025, representing 41% of global medical cannabis revenue, and is projected to surpass USD 50 billion by 2033. This growth creates a favorable regulatory and commercial environment for compliant, hemp-derived smokable products particularly in regions where THC cannabis remains restricted. In states with open cannabis access such as California, Colorado, Michigan, and New York, hemp cigarette adoption rates are rising by 28–34% annually, supported by retail diversification and rising consumer education on low-THC inhalables.
In contrast, states with restrictive cannabis policies such as Texas have witnessed growing demand for CBD herbal cigarettes as legal, accessible substitutes for THC products. Texas has one of the strictest medical cannabis systems in the U.S., requiring eligible patients to obtain a certified Texas Medical Marijuana Card under the state’s Compassionate Use Program. This certification issued through regulated telemedicine providers such as CannabisMD TeleMed ensures legally compliant and medically supervised access for qualifying patients. Due to these limitations, the state has seen a 29% increase in hemp cigarette sales between 2023 and 2025, as consumers gravitate toward THC-free, Farm Bill–compliant smoking options that offer relaxation benefits without violating state cannabis laws.
By 2025, retail penetration for hemp herbal cigarettes in the U.S. increased by 32%, fueled by convenience stores, smoke shops, online platforms, and wellness retailers adopting CBD preroll SKUs. With rising consumer substitution away from tobacco, growing wellness alignment, and expanding product innovation, the Hemp Herbal Cigarettes with CBD industry has firmly established itself as one of the fastest-growing subsegments within the global hemp economy in 2025.
Global Market Overview
The global Hemp Herbal Cigarettes with CBD market continues to expand rapidly, driven by evolving consumer behavior, the shift toward nicotine-free alternatives, and intensifying wellness-focused consumption patterns. Valued at USD 0.57 billion in 2024 and projected to reach USD 0.66 billion in 2025, the market is on track to climb to USD 1.94 billion by 2034, supported by a strong CAGR of 12.67%. Demand is being propelled by several key adoption trends: 42% of consumers choose CBD cigarettes as nicotine-free substitutes, 31% use hemp prerolls for wellness benefits, and 36% of recreational buyers prioritize flavor innovation driven by advanced terpene profiles and botanical infusions. Retail penetration is deepening as well, with 28% of global retailers introducing CBD-based herbal cigarette lines between 2024 and 2025, further expanding category availability across mainstream and specialty channels.
North America remains heavily influenced by the accelerating medical cannabis landscape in the United States. The U.S. alone accounted for 41% of global medical cannabis revenue in 2025, with market value increasing from USD 18.1 billion in 2024 to USD 20.4 billion in 2025 and expected to surpass USD 50 billion by 2033. This growth fosters a supportive environment for compliant hemp-derived CBD inhalable products, which benefit from rising consumer acceptance and evolving regulatory clarity. In states like Texas, however, access to medical cannabis is regulated through a strict, state-approved certification process. Eligible patients must obtain a Texas Medical Marijuana Card to legally purchase and use medical cannabis products. This certification available through licensed telemedicine providers such as CannabisMD TeleMed ensures safe, compliant, and medically supervised access for qualifying patients. This structured regulatory framework reinforces demand for low-THC, hemp-based smoking alternatives among consumers seeking accessible wellness-oriented substitutes.
Europe continues to scale as tobacco-reduction policies and hemp-friendly regulations stimulate demand for non-nicotine smoking options. The Asia-Pacific region, while more conservative in cannabis regulations, is emerging as a promising market through cross-border e-commerce, wellness tourism, and increasing familiarity with hemp products in countries such as Thailand, Japan, and Australia. Latin America and parts of Africa are strengthening their roles as cost-effective hemp cultivation hubs, expanding global supply capabilities and supporting price stability across export-driven markets.
Manufacturers are responding to global momentum through deeper R&D investments, organic cultivation practices, terpene-enhanced formulations, smoother filtration technologies, and expanded flavor portfolios. These advancements support consistent cannabinoid retention, improved product quality, and enhanced consumer experience. With strong cross-regional demand drivers, widening retail footprints, advancing product innovation, and the broader rise of medical and wellness cannabis markets, the global Hemp Herbal Cigarettes with CBD sector is positioned for sustained long-term growth.
U.S. Hemp Herbal Cigarettes with CBD Market Analysis
The United States remains the single most influential market in the global Hemp Herbal Cigarettes with CBD sector, contributing over 52% of total worldwide CBD cigarette sales in 2025 and accounting for nearly 0.34 billion USD of the global USD 0.66 billion market. The country’s overall cannabis ecosystem continues expanding rapidly, driven by regulatory liberalization, shifting wellness behaviors, and strong product innovation. The broader U.S. medical cannabis market reached USD 20.4 billion in 2025, representing 41% of global medical cannabis revenue, and is projected to surpass USD 50 billion by 2033, supported by a 12.7% CAGR, directly influencing the rise of hemp-smoking alternatives nationwide.
State-level demand shows strong variability, with 23 fully legalized states, 14 medical-only states, and the remaining jurisdictions maintaining partial or restrictive frameworks. California alone contributes nearly 19% of total U.S. hemp herbal cigarette sales, supported by a large adult-use population, sophisticated dispensary networks, and high adoption among wellness buyers, 42% of whom prefer CBD prerolls over vapes. Colorado, contributing 8% of national sales, remains a leader in premium terpene-infused hemp prerolls, with 37% of consumers choosing organic hemp-filter versions.
In the Eastern U.S., Florida despite being a medical-only market accounts for 11% of national CBD cigarette consumption, driven by its rapidly expanding medical user base of over 800,000 registered patients. New York, contributing 6%, is witnessing rising retail penetration after adult-use legalization, with 31% year-on-year growth in hemp preroll sales. Pennsylvania and New Jersey together generate 9%, supported by large urban centers and increasing adoption of nicotine-free smoking alternatives where 35% of users are converting away from traditional tobacco.
In Southern states, adoption is shaped by wellness interest rather than recreational policy. Texas alone contributes approximately 7% of U.S. CBD cigarette demand, despite strict THC regulations. Access to medical cannabis in Texas is controlled through a state-certified process, requiring eligible patients to obtain a Texas Medical Marijuana Card. This certification provided through licensed telemedicine networks such as CannabisMD TeleMed ensures legal, medically supervised access to qualified patients. These restrictions have accelerated demand for compliant, low-THC hemp herbal cigarettes, with 29% growth in Texas hemp preroll sales between 2023 and 2025.
In the West and Midwest, states like Washington, Oregon, Michigan, and Illinois collectively generate 17% of national demand, supported by high wellness adoption and over 2.3 million combined medical and adult-use consumers. Meanwhile, conservative states in the central U.S. including Kansas, Idaho, and Nebraska maintain restrictive cannabis policies, yet still experience annual CBD cigarette e-commerce growth exceeding 14%, driven by nicotine-free interest and cross-border retail.
Regulatory Landscape
The regulatory environment for Hemp Herbal Cigarettes with CBD in the United States is shaped by a complex interplay of federal rules, state-level cannabis frameworks, and evolving commercial standards. At the federal level, the 2018 Farm Bill legalized hemp containing 0.3% THC or less, enabling nationwide distribution of CBD-based herbal cigarettes. This federal legalization supports a market where over 74% of CBD cigarette brands rely on interstate supply chains, while more than 62% of retail distributors operate across multiple states. However, regulatory clarity remains uneven, as the FDA continues evaluating CBD inhalable products, contributing to an estimated 18% compliance variance between states with stricter health department oversight and those permitting open hemp commerce.
State-level regulatory differences significantly influence demand patterns. As of 2025, 23 states have full adult-use cannabis legality, 14 maintain medical-only frameworks, and the remaining jurisdictions impose restrictive or minimal cannabis policies. In states with strong regulatory alignment such as Colorado, Oregon, and Michigan CBD herbal cigarettes achieve market penetration rates above 28% within smoke shops and dispensaries. Conversely, restrictive states such as Idaho and Kansas limit THC and CBD inhalables, pushing over 16% of consumer purchases to online channels or cross-border retail activity.
Texas represents one of the most regulated environments affecting consumer access to cannabis-related products, shaping higher-than-average adoption of hemp-derived alternatives. In Texas, access to medical cannabis is controlled through a state-approved, highly regulated certification process under the Compassionate Use Program (CUP). Eligible patients must obtain a Texas Medical Marijuana Card to legally purchase and use medical cannabis products, ensuring compliance and medical oversight. This certification issued through licensed telemedicine providers such as CannabisMD TeleMed supports regulated access for qualifying patients. Texas currently has over 98,000 registered medical cannabis participants, reflecting annual growth of 22%, and contributes to rising demand for compliant hemp herbal cigarettes, which contain zero psychoactive THC and remain fully legal statewide.
Across the U.S., compliance testing, THC-level enforcement, labeling standards, and age restrictions continue to strengthen. Over 68% of CBD cigarette manufacturers now comply with full-panel third-party lab testing, while 34 states mandate QR-coded certificates of analysis (COAs) on product packaging. Retail regulations also vary, with 21 states requiring age-verification systems for hemp inhalables and 11 states implementing specific taxation rules for CBD smoking products.
Collectively, the evolving regulatory landscape balancing federal hemp law, state cannabis policies, product safety rules, and monitored patient access continues to shape market expansion, consumer trust, and long-term investment attractiveness across the U.S. Hemp Herbal Cigarettes with CBD industry.
Global Growth Insights unveils the top List Global Hemp Herbal Cigarettes with CBD Companies:
| Company Name | Headquarters | Past-Year Revenue (USD) | Estimated CAGR | Geographic Presence | Key Highlight |
|---|---|---|---|---|---|
| NuLeaf Naturals | Denver, Colorado, USA | 54 Million | 11.2% | North America, Europe | Leading producer of full-spectrum CBD oils expanding into hemp cigarette lines. |
| Terra Tech | Irvine, California, USA | 38 Million | 9.6% | USA, Canada | Diversified cannabis operator investing in hemp inhalable product innovation. |
| Bhang Corporation | Miami, Florida, USA | 22 Million | 8.8% | North America, Latin America | Premium cannabis and CBD brand entering terpene-rich hemp cigarette formats. |
| Heimat | Zurich, Switzerland | 18 Million | 10.5% | Europe, Asia | Known for Europe’s first legal hemp cigarette with low-THC compliant blends. |
| Mentor Capital | Ramona, California, USA | 10 Million | 7.9% | USA | Investment firm backing multiple CBD inhalable brands and vertical operations. |
| CBD American Shaman | Kansas City, Missouri, USA | 95 Million | 13.4% | USA (400+ stores) | Major CBD retailer expanding hemp preroll SKUs across national franchise outlets. |
| Medical Marijuana, Inc. | San Diego, California, USA | 68 Million | 10.8% | North America, South America, Europe | One of the first publicly traded cannabis companies with global hemp operations. |
| Cannoid | Louisville, Colorado, USA | 15 Million | 12.1% | USA, EU | Specializes in cannabinoid formulations now scaling hemp inhalable R&D. |
| Altria Group Inc. | Richmond, Virginia, USA | 21.2 Billion | 4.1% | Global | Tobacco giant investing heavily in hemp-cigarette and reduced-risk product categories. |
| Meadow Care | Los Angeles, California, USA | 6 Million | 9.2% | USA | Emerging CBD wellness brand entering artisan hemp cigarette segment. |
| Pharmahemp | Ljubljana, Slovenia | 42 Million | 11.6% | Europe, Asia, Middle East | EU-GMP certified producer supplying smokable hemp products globally. |
| Aurora Cannabis | Edmonton, Canada | 223 Million | 5.7% | Global (25+ countries) | Large-scale cannabis producer with growing hemp preroll and export portfolio. |
| United Cannabis | Denver, Colorado, USA | 8 Million | 9.0% | USA | Focused on medical formulations and CBD inhalable therapeutic blends. |
| mCig | Henderson, Nevada, USA | 5 Million | 7.4% | USA | Developer of vapor and smokable hemp technologies targeting niche markets. |
| Canopy Growth Corporation | Smiths Falls, Ontario, Canada | 289 Million | 6.2% | Global (multiple continents) | Major cannabis corporation expanding into hemp cigarettes via strategic partnerships. |
| Cronos Group | Toronto, Canada | 86 Million | 9.7% | North America, Israel, Europe | Backed by Altria; scaling hemp inhalable R&D and global distribution. |
CBD Hemp Cigarette Industry Companies Highlights -2025
In 2025, the Hemp Herbal Cigarettes with CBD sector experienced notable corporate advancements, driven by expanded production capacity, regulatory alignment, and accelerated retail penetration. NuLeaf Naturals reported a 14% increase in CBD preroll sales, supported by a nationwide distribution expansion into 1,200 retail outlets. Terra Tech completed a product diversification initiative, adding three terpene-rich hemp cigarette SKUs, contributing to a 9% revenue uplift across its smokable category. Bhang Corporation launched a cannabinoid-flavor–infusion technology, boosting its premium preroll segment by 22% year-over-year.
European leader Heimat expanded exports into six additional EU markets, resulting in a 17% production scale increase. CBD American Shaman continued its aggressive U.S. rollout, adding 72 new franchise stores in 2025, helping drive a 13.4% annual growth rate for its hemp cigarette division. Medical Marijuana, Inc. recorded a 10% growth in international orders, fueled by Latin American wholesale demand.
Major corporates also intensified their presence. Altria Group Inc. invested in two hemp-cigarette startups, increasing its alternative-smoke portfolio revenue by 6%. Canopy Growth expanded its U.S. hemp operations, reporting a 12% increase in low-THC smokable sales, while Cronos Group accelerated R&D spending by 18% to improve biomolecule-enhanced hemp blends.
Regional Market Share & Hemp Herbal Cigarettes with CBD Opportunities
The global Hemp Herbal Cigarettes with CBD market demonstrates uneven but rapidly expanding regional penetration. In 2025, North America accounts for 48% of global market share, driven by strong adoption in the U.S., which alone contributes over 34% of global CBD cigarette revenues. Canada represents an additional 14% share, supported by federally legal cannabis laws and widespread availability of compliant hemp prerolls. Region-wide retail penetration in North America increased by 31% between 2023 and 2025, and more than 52% of CBD cigarette brands in the region now offer terpene-enhanced blends, signaling continual product innovation as a competitive advantage.
Europe holds 29% of global market share, making it the second-largest region. Switzerland, Slovenia, Germany, and Italy lead in production and consumption, collectively accounting for over 18% of the European market. Strict tobacco-reduction policies across the EU and demand for nicotine-free alternatives have driven 22% year-on-year growth in hemp preroll sales. Switzerland maintains a leadership position due to its early regulatory clarity on low-THC products and contributes 9% of global manufacturing output. Europe’s opportunity lies in growing cross-border e-commerce markets, where over 41% of consumers prefer hemp cigarettes over CBD vapes, citing smoother inhalation and natural plant aroma profiles.
Asia-Pacific represents 11% of global market share, with growth led by Australia, Japan, Thailand, and select Southeast Asian markets. The region saw 17% annual growth in hemp cigarette imports in 2024–2025 due to increasing wellness tourism and expanding consumer awareness of CBD products. Thailand contributes over 32% of regional demand, supported by relaxed cannabis laws and rapid retail expansion. Although regulatory landscapes across Asia remain conservative, emerging opportunities include premium hemp blends, wellness-targeted herbal formulations, and cross-border delivery through regulated e-commerce channels.
Latin America accounts for 7% of global share, with Colombia, Uruguay, and Brazil leading due to low cultivation costs and expanding hemp flower export industries. The region experienced 19% annual growth in hemp cigarette production capacity in 2025, driven by international partnerships and government incentives for agricultural development. Opportunities include large-scale cultivation, processing hubs, and white-label manufacturing for North American and European brands.
The Middle East & Africa (MEA) holds 5% market share, with South Africa and Lesotho emerging as key production zones. South Africa recorded 24% year-on-year growth in hemp cultivation for smokable products. Regional opportunities include bulk hemp-export supply chains, niche organic blends, and wellness-focused smoking alternatives.
Global Distribution of Hemp Herbal Cigarettes with CBD Manufacturers by Country in 2025
| Country | Market Share (%) | Number of Manufacturers | Regional Influence Score (1–10) | Key Drivers |
|---|---|---|---|---|
| United States | 38% | 85+ | 10 | Strong medical cannabis market, retail penetration, innovation in hemp prerolls. |
| Canada | 14% | 30+ | 8 | Legal cannabis framework, major LPs investing in hemp cigarette lines. |
| Switzerland | 9% | 15+ | 7 | Low-THC hemp cigarette pioneers, EU exports, premium-quality hemp flower. |
| Slovenia | 6% | 12+ | 7 | EU-GMP hemp processing, global distribution capabilities. |
| Germany | 5% | 10+ | 6 | Rising tobacco-reduction demand, regulated hemp retail markets. |
| United Kingdom | 4% | 8+ | 5 | Growing CBD wellness adoption, increasing smoke-free alternatives. |
| Italy | 4% | 8–10 | 5 | Legal hemp flower retailing, tobacco alternative trends. |
| Netherlands | 3% | 6+ | 5 | Coffee shop culture, hemp product experimentation. |
| Australia | 3% | 6+ | 4 | Medical cannabis framework, wellness-driven hemp demand. |
| China | 3% | 12+ | 6 | Large-scale hemp cultivation, export-oriented processing. |
| India | 2% | 5+ | 4 | Emerging wellness market, growing hemp cultivation regions. |
| Latvia | 2% | 4+ | 4 | EU-compliant hemp flower production and export activities. |
| Colombia | 2% | 5+ | 4 | Low-cost hemp farming and export advantages. |
| South Africa | 2% | 5+ | 4 | Legal hemp farming expansion, export-driven manufacturers. |
| Other Countries | 5% | 20+ collectively | Diverse small-scale producers across EU, LATAM, and APAC regions. |
Conclusion
The Hemp Herbal Cigarettes with CBD market is entering a decisive phase of expansion, supported by accelerating consumer adoption, regulatory evolution, and product innovation across global regions. With the industry reaching USD 0.66 billion in 2025 and projected to grow rapidly toward USD 1.94 billion by 2034, the sector has firmly transitioned from a niche smoking alternative to a mainstream wellness-oriented category. Consumer behavior continues to shift, with 42% choosing CBD cigarettes as nicotine-free substitutes, 31% seeking relaxation and wellness benefits, and 36% prioritizing enhanced flavor and terpene profiles, collectively shaping a dynamic demand landscape.
The U.S. remains the anchor of global growth, benefiting from a robust USD 20.4 billion medical cannabis market in 2025, representing 41% of global revenue. Even in restrictive environments such as Texas, where access requires a state-certified Texas Medical Marijuana Card through regulated providers like CannabisMD TeleMed consumer appetite for compliant, low-THC hemp alternatives continues to rise. This blend of regulatory constraint and consumer demand has pushed hemp cigarettes into new relevance as legally accessible wellness inhalables.
Across Europe, Asia-Pacific, Latin America, and Africa, opportunities are expanding through tobacco reduction policies, wellness tourism, large-scale hemp cultivation, and cross-border e-commerce. Leading companies are accelerating strategic advancements, from organic supply chain development to terpene-engineered product lines, while major corporations like Altria, Cronos, and Canopy Growth fuel category growth through investment and global distribution networks.
As the market continues maturing, competitive advantage will be shaped by innovation in formulation, quality consistency, regulatory compliance, and geographical positioning. With growing demand for nicotine-free solutions and increasing global acceptance of hemp-based products, Hemp Herbal Cigarettes with CBD are well positioned to become one of the fastest-growing segments within the broader hemp and wellness economy throughout the next decade.